본문 바로가기
주메뉴 바로가기
HLBELL
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
Sitemap
Contact
ENG
KOR
ENG
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
SITEMAP
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
PR
Biotech Company Specialized in Regenerative Medicine
News
Notice
News
News
라이프리버, 바이오인공간 임상2b상 식약처 승인
Date 2020.09.04
Hit 1628
기사원문 : https://
www.news1.kr/articles/?3477638
PREV
명지의료재단-에이치엘비그룹, 의료사업 등 협력
NEXT
라이프리버,간줄기세포치료제 ‘헤파스템’ 2b상임상계획승인
LIST